A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS)
Publication
, Conference
Peters, P; Gonzalez, R; Havrilesky, L; Berchuck, A; Strickler, J; Green, M; Datto, M; McKinney, M; Menendez, C; Strickland, K; Previs, R
Published in: Gynecologic Oncology
2022
Duke Scholars
Published In
Gynecologic Oncology
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2022
Volume
166
Start / End Page
S152 / S152
Related Subject Headings
- Oncology & Carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, P., Gonzalez, R., Havrilesky, L., Berchuck, A., Strickler, J., Green, M., … Previs, R. (2022). A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS). In Gynecologic Oncology (Vol. 166, pp. S152–S152).
Peters, Pamela, Rafael Gonzalez, Laura Havrilesky, Andrew Berchuck, John Strickler, Michelle Green, Michael Datto, et al. “A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS).” In Gynecologic Oncology, 166:S152–S152, 2022.
Peters P, Gonzalez R, Havrilesky L, Berchuck A, Strickler J, Green M, et al. A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS). In: Gynecologic Oncology. 2022. p. S152–S152.
Peters, Pamela, et al. “A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS).” Gynecologic Oncology, vol. 166, 2022, pp. S152–S152.
Peters P, Gonzalez R, Havrilesky L, Berchuck A, Strickler J, Green M, Datto M, McKinney M, Menendez C, Strickland K, Previs R. A quality improvement initiative to increase genetic testing referrals after identification of hereditable high-risk mutations on next generation sequencing (NGS). Gynecologic Oncology. 2022. p. S152–S152.
Published In
Gynecologic Oncology
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2022
Volume
166
Start / End Page
S152 / S152
Related Subject Headings
- Oncology & Carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis